Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain
ConditionOsteoarthritis Knee Pain
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age40+
SponsorSaol Therapeutics Inc
About this trial
A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.
Eligibility criteria
Qualifiers
Male or female patients ≥ 40 years of age
Body Mass Index (BMI) limits
Chronic knee pain resulting from osteoarthritis
Kellgren-Lawrence Grade 2 (mild) or Grade 3 (moderate)
Disqualifiers
Non-OA inflammatory arthritis
Confounding elements
Lower limb amputation.
Specified alternate historic treatments
Trial design
Treatments tested in this trial
- SL1002
- Normal Saline
Treatment groups
150 Participants
are divided into 2 treatment groupsLocations
21California
Sutter Neurology and Pain Management95661, Roseville United States
Innovative Pain Treatment Solutions92111, San Diego United States
Colorado
DBPS Research, LLC80111, Greenwood Village United States
District of Columbia
International Spine, Pain & Performance Center20006, Washington D.C. United States
Sponsors and collaborators
Saol Therapeutics Inc
Lead sponsor
Source ClinicalTrials.gov